Clinical Pharmacology and Drug Toxicity Practice Questions

Q: Which among the following drugs is contraindicated in renal failure?

Pethidine. **Explanation:** **Pethidine (Meperidine)** is the correct answer because of its metabolic profile. It is metabolized in the liver to **norpethidine**, a toxic metabolite. Norpethidine is primarily excreted by the kidneys. In patients with renal failure, norpethidine accumulates, leading to CNS hyper-excitability. This manifests as tremors, myoclonus, and potentially fatal **seizures**. Unlike opioid overdose, these seizures are not reversed by Naloxone; in fact, Naloxone may worsen them by lowering the seizure threshold. **Analysis of Incorrect Options:** * **Morphine:** While its metabolite (Morphine-6-glucuronide) can accumulate in renal failure and cause prolonged respiratory depression, it is not strictly contraindicated; it can be used with extreme caution and dose adjustment. Pethidine is more dangerous due to the seizure risk. * **Fentanyl:** This is considered the **opioid of choice** in renal failure. It has no active metabolites and is primarily cleared by hepatic metabolism, making it safe for patients with impaired kidney function. * **Atracurium:** This neuromuscular blocker undergoes **Hofmann elimination** (spontaneous non-enzymatic degradation in the plasma). Its clearance is independent of renal or hepatic function, making it safe in renal failure. **High-Yield Clinical Pearls for NEET-PG:** * **Pethidine + MAO Inhibitors:** Can cause "Serotonin Syndrome" (hyperpyrexia, coma). * **Drug of choice in Renal Failure:** Fentanyl (Opioid), Atracurium/Cisatracurium (Muscle relaxant). * **Pethidine** is preferred over Morphine in biliary colic because it causes less spasm of the Sphincter of Oddi.

Q: In oral poisoning with carbamate insecticide, which of the following may be hazardous?

Pralidoxime. **Explanation:** The correct answer is **A. Pralidoxime**. **1. Why Pralidoxime is hazardous in Carbamate poisoning:** Carbamates (e.g., Neostigmine, Physostigmine, Carbaryl) cause reversible inhibition of acetylcholinesterase (AChE) by carbamylation of the enzyme's esteratic site [1]. Unlike organophosphates (OP), carbamates do not undergo "aging." Pralidoxime (an oxime) is a cholinesterase reactivator designed to displace the phosphate group in OP poisoning [2]. However, in carbamate poisoning, the enzyme-carbamate bond is transient and dissociates spontaneously. Adding Pralidoxime can be hazardous because: * Oximes themselves have weak anticholinesterase activity, which can worsen the cholinergic crisis. * Specifically, in **Carbaryl** poisoning, oximes significantly increase the toxicity of the carbamate. **2. Why other options are incorrect:** * **B. Atropine:** This is the **drug of choice** for carbamate poisoning. It competitively antagonizes the muscarinic effects of accumulated acetylcholine. * **C. Magnesium sulfate purgative:** Used to hasten the elimination of the unabsorbed poison from the GI tract. It is a standard supportive measure. * **D. Gastric lavage with activated charcoal:** This is a standard decontamination procedure to prevent further absorption of the toxin if the patient presents within the "golden hour." **Clinical Pearls for NEET-PG:** * **Rule of Thumb:** "Atropine for all, Oximes for OP only." * **Exception:** While oximes are generally contraindicated in carbamates, some guidelines suggest they may be used if there is a **mixed poisoning** (OP + Carbamate) or if the specific toxin is unknown, provided Atropine is already administered. * **Key Difference:** Carbamates = Reversible inhibition (No aging); Organophosphates = Irreversible inhibition (Aging occurs).

Q: Which of the following drugs requires therapeutic drug monitoring?

Phenytoin. ### Explanation **Correct Option: D (Phenytoin)** Phenytoin is a classic candidate for **Therapeutic Drug Monitoring (TDM)** due to its unique pharmacokinetic profile. It follows **zero-order (non-linear) kinetics** at therapeutic concentrations. This means that as the metabolic enzymes (CYP2C9) become saturated, even a small increase in dose can lead to a disproportionately large increase in plasma concentration, resulting in toxicity. Additionally, Phenytoin has a **narrow therapeutic index** (10–20 µg/mL), where the margin between the effective dose and the toxic dose is very slim. **Analysis of Incorrect Options:** * **A. Metformin:** Its efficacy is monitored by clinical parameters like blood glucose levels and HbA1c. It has a wide safety margin and predictable kinetics. * **B. Propranolol:** The clinical response (reduction in heart rate or blood pressure) is easily measurable at the bedside, making plasma level monitoring unnecessary. * **C. Warfarin:** While Warfarin has a narrow therapeutic index, it is monitored using **PT/INR** (a pharmacodynamic marker) rather than measuring the drug concentration in the blood. **High-Yield Clinical Pearls for NEET-PG:** * **Criteria for TDM:** Narrow therapeutic index, high inter-individual variability, non-linear kinetics, and lack of easily measurable clinical markers. * **Mnemonic for TDM Drugs:** "**L**earn **T**he **V**ery **P**oisonous **D**rugs **C**arefully" (**L**ithium, **T**heophylline/Tricyclic antidepressants, **V**alproate, **P**henytoin, **D**igoxin, **C**yclosporine). * **Phenytoin Toxicity:** Characterized by nystagmus (earliest sign), ataxia, and gum hypertrophy. * **Exception:** If a drug has a measurable physiological effect (e.g., BP for antihypertensives, INR for Warfarin), TDM is generally not required.

Q: Therapeutic drug monitoring is required for which of the following drugs?

Gentamycin. **Explanation:** Therapeutic Drug Monitoring (TDM) is essential for drugs with a **narrow therapeutic index**, where the difference between the effective dose and the toxic dose is minimal, and for drugs where plasma concentration correlates better with clinical effect than dosage. **Why Gentamycin is Correct:** Gentamycin is an aminoglycoside with a narrow therapeutic window. It is associated with significant **nephrotoxicity** and **ototoxicity**. Monitoring peak levels ensures efficacy (concentration-dependent killing), while monitoring trough levels is critical to prevent accumulation and minimize toxicity. TDM is mandatory for aminoglycosides, especially in patients with renal impairment or those on prolonged therapy. **Why the Other Options are Incorrect:** * **Sulfonamides:** These are monitored based on clinical response and the appearance of adverse effects (like rashes or crystalluria) rather than plasma levels. * **Metformin:** Its efficacy is monitored by blood glucose levels and HbA1c. Plasma level monitoring does not correlate directly with its clinical management. * **Cycloserine:** While it is a second-line antitubercular drug with neurotoxic potential, it is not a standard candidate for routine TDM in general clinical practice compared to aminoglycosides. **High-Yield Clinical Pearls for NEET-PG:** * **Mnemonic for TDM drugs:** "**L**earn **T**he **D**rugs **Q**uickly **A**nd **P**revent **V**ery **F**atal **E**rrors" (**L**ithium, **T**ricyclic antidepressants/Theophylline, **D**igoxin, **Q**uinidine, **A**minoglycosides, **P**henytoin, **V**alproate, **F**lecanide, **E**thosuximide). * **Exceptions:** TDM is **not** required for drugs with a wide therapeutic index (e.g., Penicillin) or drugs whose effect is easily measured (e.g., Warfarin via PT/INR, Antihypertensives via BP).

Q: Which of the following congenital malformations is seen in a child whose mother was treated with oral anticoagulants during pregnancy?

Craniofacial malformations. **Explanation:** The question refers to **Fetal Warfarin Syndrome (Warfarin Embryopathy)**. Warfarin is a low-molecular-weight oral anticoagulant that crosses the placenta and is highly teratogenic, especially when administered during the first trimester (6th–9th week of gestation). **1. Why Craniofacial Malformations is Correct:** Warfarin interferes with the synthesis of vitamin K-dependent proteins required for bone and cartilage formation (specifically osteocalcin). This leads to classic **craniofacial abnormalities**, most notably **midface hypoplasia** and a **depressed/saddled nasal bridge**. Other features include stippled epiphyses (chondrodysplasia punctata) and ophthalmic defects like optic atrophy. **2. Why Incorrect Options are Wrong:** * **Renal agenesis:** This is not a characteristic feature of Warfarin embryopathy. Renal malformations are more commonly associated with drugs like **ACE inhibitors** (which cause renal dysgenesis and oligohydramnios). * **Long bone defects:** While Warfarin causes stippling of the epiphyses and can lead to **limb hypoplasia** (shortened fingers/limbs), it does not typically cause gross "long bone defects" in the same way it affects the facial skeleton and axial cartilage. * **All of the above:** Since renal agenesis is not part of the syndrome, this option is incorrect. **High-Yield Clinical Pearls for NEET-PG:** * **Safe Alternative:** **Heparin** (both UFH and LMWH) does not cross the placenta and is the anticoagulant of choice during pregnancy. * **Critical Period:** Exposure in the **1st trimester** causes embryopathy; exposure in the **2nd/3rd trimesters** increases the risk of fetal CNS hemorrhage and microcephaly. * **Key Buzzwords:** "Nasal hypoplasia" and "Stippled epiphyses" are the most frequently tested features of Fetal Warfarin Syndrome.

Question 1

What is the antidote for poisoning due to Amanita muscaria?

Accepted Answer

Atropine

Answer

Physostigmine

Answer

Amyl nitrite

Answer

Methylene blue

Question 2

Which among the following drugs is contraindicated in renal failure?

Accepted Answer

Pethidine

Answer

Morphine

Answer

Fentanyl

Answer

Atracurium

Question 3

Teratogenicity results when drugs are given during which period of gestation?

Accepted Answer

First trimester

Answer

Second trimester

Answer

Third trimester

Answer

Soon after birth

Question 4

In oral poisoning with carbamate insecticide, which of the following may be hazardous?

Accepted Answer

Pralidoxime

Answer

Atropine

Answer

Magnesium sulfate purgative

Answer

Gastric lavage with activated charcoal

Question 5

Which of the following drugs requires therapeutic drug monitoring?

Accepted Answer

Phenytoin

Answer

Metformin

Answer

Propranolol

Answer

Warfarin

Question 6

Therapeutic drug monitoring is required for which of the following drugs?

Accepted Answer

Gentamycin

Answer

Sulfonamides

Answer

Metformin

Answer

Cycloserine

Question 7

A 30-year-old male is taking methotrexate 7.5 mg once daily for arthritis and wishes to start a family. His wife takes no other medication apart from oral contraceptive pills. What advice should be given before conception?

Accepted Answer

The husband should stop methotrexate, and the wife should continue contraception for 3 months.

Answer

The husband should stop methotrexate, and the wife should continue contraception for 1 year.

Answer

The wife should conceive immediately, but the husband should stop methotrexate.

Answer

Consider adoption.

Question 8

Individuals with alcoholic cirrhosis of the liver may develop severe hepatotoxicity after doses of acetaminophen that are not toxic to individuals with normal liver function. This increased sensitivity to acetaminophen's toxicity is due to:

Accepted Answer

Decreased hepatocellular stores of glutathione

Answer

Decrease availability of acetaldehyde dehydrogenase

Answer

Decreased activity of Cytochrome P450 enzymes

Answer

Increased liver blood flow

Question 9

Which of the following congenital malformations is seen in a child whose mother was treated with oral anticoagulants during pregnancy?

Accepted Answer

Craniofacial malformations

Answer

Renal agenesis

Answer

Long bone defects

Answer

All of the above

Question 10

The sensitive period for tetracycline-induced tooth discoloration in the permanent maxillary and mandibular incisors and canines is:

Accepted Answer

3 months postpartum to 7th year of life

Answer

4 months in utero to 3 months postpartum

Answer

5 months in utero to 9 months postpartum

Answer

Birth to 7th year

Clinical Pharmacology and Drug Toxicity — MCQs

Clinical Pharmacology and Drug Toxicity — MCQs

On this page

Practice by Chapter

Want unlimited practice?